Merck’s HPV Vaccine May Protect Girls With Fewer Doses

Two doses of Merck & Co.’s human papillomavirus vaccine may be just as effective in younger girls as the recommended three doses given to older teens and women to help protect them against the virus that causes cervical cancer, a Canadian study found.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.